Document is current
Any future updates will be listed below
-
Authors
Zheng, Di
Bhuvan, Tejasvini
Payne, Natalie L.
Pang, Swee H. M.
Mendonca, Senora
Hutchinson, Mark R.
McKinnirey, Flyn
Morgan, Charlotte
Vesey, Graham
Meagher, Laurence
Heng, Tracy S. P. https://orcid.org/0000-0003-4147-8986
-
Funding
Funding for this research was provided by:
Australian Research Council (IC190100026, FT180100565, IC190100026)
National Health and Medical Research Council of Australia (GNT1162499, GNT2012290)
Australian Government Research Training Program (Australian Government Research Training Program, Australian Government Research Training Program)
- License Information
-
More Information
Article History
Received: 16 August 2024
Accepted: 8 November 2024
First Online: 17 November 2024
Declarations
:
: All animal experiments received approval from Monash University Animal Ethics Committee (Project title: Mesenchymal stromal cells and the innate immune system; Approval number: 23407; Date of approval: 01/04/2020) and were performed in accordance with the guidelines of the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. Human MSCs were isolated from healthy donor lipoaspirate, performed with informed patient consent in accordance with Monash University Human Research Ethics Committee (Project title: Immunomodulatory properties of different stem cell types; Approval number: 2007/1798; Date of approval: 10/10/2007).
: Not applicable.
: TSPH had received funding from Regeneus Ltd. MRH had also undertaken other related funded research for Regeneus Ltd. FM, CM and GV were employees of Regeneus Ltd. The funders were not involved in the study design, collection, analysis or interpretation of data, the writing of this article or the decision to submit it for publication. The remaining authors declare no competing interests.
